TL;DR: CHF 1243 (CAS 105441-20-1) is a chemical compound with molecular formula C14H21NO4S and molecular weight 299.11914 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
1,2,2-trimethyl-3-[(2-oxothiolan-3-yl)carbamoyl]cyclopentane-1-carboxylic acid
Also Known As: CHF 1243, 1,2,2-trimethyl-3-[(2-oxothiolan-3-yl)carbamoyl]cyclopentane-1-carboxylic acid, 1,2,2-trimethyl-3-[(2-oxothiolan-3-yl)carbamoyl]cyclopentane, Cyclopentanecarboxylic acid, 3-(((2-oxotetrahydro-3-thienyl)amino)carbonyl)-1(and 3),2,2-trimethyl-, Cyclopentanecarboxylicacid, 1,2,2-trimethyl-3-[[(tetrahydro-2-oxo-3-thienyl)amino]carbonyl]-
| Molecular Formula | C14H21NO4S |
| Molecular Weight | 299.11914 g/mol |
| XLogP | 1.7 |
| Topological Polar Surface Area (TPSA) | 109.0 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Exact Mass | 299.11914 Da |
| Heavy Atoms | 20 |
| Complexity | 462.0 |
| SMILES | CC1(C(CCC1(C)C(=O)O)C(=O)NC2CCSC2=O)C |
| InChIKey | ATVCYNBHYNPTPC-UHFFFAOYSA-N |
The XLogP value of 1.7 suggests moderate lipophilicity, balancing water solubility and membrane permeability for CHF 1243. The TPSA of 109.0 Ų falls within the moderate polarity range, balancing permeability and solubility for CHF 1243. Following Lipinski's Rule of Five, CHF 1243 has 2 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of CHF 1243 is 105441-20-1.
The molecular formula of CHF 1243 is C14H21NO4S.
The molecular weight of CHF 1243 is 299.11914 g/mol.
You can request a quote for CHF 1243 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for CHF 1243 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 105441-20-1. Our professional technical team will respond with pricing and lead time.